Intrathoracic hyperthermic chemotherapy: facts and fables

T. Markowiak (Regensburg, Germany)

Source: Virtual Congress 2021 – Diagnostic and therapeutic advances in mesothelioma care
Session: Diagnostic and therapeutic advances in mesothelioma care
Session type: Symposium
Number: 1240

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Markowiak (Regensburg, Germany). Intrathoracic hyperthermic chemotherapy: facts and fables. Virtual Congress 2021 – Diagnostic and therapeutic advances in mesothelioma care

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LATE-BREAKING ABSTRACT: Cytoreduction surgery and hypertermic intraoperative intrapleural chemotherapy for malignant pleural diseases: initial experience
Source: International Congress 2014 – Risk assessment and tracheal reconstructions
Year: 2014



Induction chemotherapy before lung cancer resection: experiences and perspectives
Source: Eur Respir J 2004; 24: Suppl. 48, 302s
Year: 2004

Pleurectomy, decortication and hyperthermic chemotheraphy in malignant pleural mesothelioma, a single institution experience
Source: International Congress 2017 – General thoracic surgery
Year: 2017

Mesothelioma: is chemotherapy alone a thing of the past?
Source: Eur Respir Monogr 2020; 87: 232-249
Year: 2020


Surgery and multimodality treatment for malignant pleural mesothelioma
Source: Eur Respir Mon; 2009: 44: 407–418
Year: 2009

Radiation oncology perceptive: radiotherapist considerations for concurrent chemo-RT
Source: ERS Skills course: Multi-disciplinary care in thoracic oncology
Year: 2019

Carcinomatous lymphangitis of a tracheal bifurcation in lung cancer: the role of neoadjuvant chemotherapy followed by surgery
Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery
Year: 2008


Pulmonary function changes after chemotherapy and radiotherapy for Lymphoma.
Source: International Congress 2017 – Case reports and series
Year: 2017

Pulmonary toxicity during chemotherapy with etopiside and carboplatin
Source: Eur Respir J 2003; 22: Suppl. 45, 64s
Year: 2003

Radiotherapy: a novel treatment for pneumothorax
Source: Eur Respir J 2006; 27: 427-429
Year: 2006



Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour
Source: Eur Respir J 2007; 29: 117-126
Year: 2007



Systemic therapy 1 in malignant pleural mesothelioma: chemotherapy
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020

Chemotherapy
Source: Eur Respir Monogr 2015; 68: 186-201
Year: 2015


Late Breaking Abstract - Comparison of VATS debulking surgery and HITHOC vs VATS talc pleurodesis alone in malignant pleural mesothelioma: a pilot study
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020